Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level

Allopurinol is the first-line agent for patients with gout, including those with moderate‐to‐severe chronic kidney disease. However, increased thyroid-stimulating hormone (TSH) levels are observed in patients with long-term allopurinol treatment. This large-scale, nested case–control, retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Wona, Yang, Yoon-Sik, Chang, Dong-Jin, Chung, Yeon Woong, Kim, HyungMin, Ko, Soo Jeong, Yoo, Sooyoung, Oh, Ji Seon, Kang, Dong Yoon, Yang, Hyeon-Jong, Choi, In Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514499/
https://www.ncbi.nlm.nih.gov/pubmed/34645831
http://dx.doi.org/10.1038/s41598-021-98954-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514499/
https://www.ncbi.nlm.nih.gov/pubmed/34645831
http://dx.doi.org/10.1038/s41598-021-98954-1

Ejemplares similares